Herbalife Ltd. Announces Record First Quarter 2011 Results and Raises FY'11 Guidance

    --  First quarter net sales growth of 28.5 percent on volume growth of 21.5
        percent.
    --  First quarter adjusted1EPS of $1.43 increased 45.9 percent compared to
        the $0.98 adjusted1EPS from prior year period.
    --  Raises FY'11 EPS guidance to a range of $5.54 to $5.78.
    --  Shareholders approve 2 for 1 stock split with a record date May 10,
        2011.
    --  Board of directors approved a post stock-split quarterly dividend of
        $0.20 per share.

LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE:HLF) today reported that first quarter net sales increased 28.5 percent and local currency net sales increased 24.7 percent compared to the same time period in 2010. Adjusted1 net income for the quarter of $88.3 million, or $1.43 per diluted share compares to 2010 first quarter adjusted net income and EPS of $61.5 million and $0.98, respectively. On a reported basis, first quarter 2011 EPS of $1.41 increased 70 percent compared to the $0.83 reported in the comparable quarter last year.

"Our ongoing efforts to globalize daily consumption-based distributor methods of operation (DMOs) continued to provide strong growth to both the top and bottom line growth in the first quarter," said Michael O. Johnson, the company's chairman and CEO. "The company's strategic focus to provide solutions for two large mega trends, the global obesity epidemic and the desire for people to earn more income, continues to provide a large platform for us to succeed. The company will continue to invest to support our growth with such initiatives as the Seed to Feed verticalization strategy."

For the quarter ended March 31, 2011, the company generated cash flow from operations of $107.5 million, an increase of 23.0 percent compared to the first quarter 2010, paid dividends of $14.8 million and invested $28.3 million in capital expenditures.


_______________________

1  See Schedule B - "Reconciliation of Non-GAAP Financial Measures" for more
   detail.



First Quarter 2011 Regional Key Metrics2,3

Regional Volume Point and Average Active Sales Leader Metrics


                           Volume Points (Mil)    Average Active Sales Leaders

Region                     1Q'11   Yr/Yr % Chg    1Q'11     Yr/Yr % Chg

North America              243.0   10.4 %         52,549    14.7 %

Asia Pacific               198.7   30.6 %         40,510    27.0 %

EMEA                       138.0   15.5 %         35,960    12.2 %

Mexico                     164.5   32.4 %         42,480    23.2 %

South & Central America    125.1   23.7 %         30,970    13.8 %

China                      32.8    28.1 %         7,272     36.7 %

Worldwide Total            902.1   21.5 %         205,036   20.8 %

                           Volume Points (Mil)    Average Active Sales Leaders

                           1Q'11   Yr/Yr % Chg    1Q'11     Yr/Yr % Chg

Emerging Markets           475.2   29.1 %         113,176   25.8 %

Established Markets        426.9   14.0 %         95,392    16.2 %

Worldwide Total            902.1   21.5 %         205,036   20.8 %




_______________________

   "Emerging markets" are defined herein as those countries that the World Bank
2  categorized as having "low" or "medium" GDP per capita, while "Established
   markets" are defined as those countries categorized by the World Bank as
   having "high" GDP per capita.

3  Supplemental tables that include additional business metrics can be found at
   http://www.ir.herbalife.com



Updated 2011 Guidance

Based on current business trends and foreign currency rates, the company's second quarter and fiscal 2011 guidance is provided below.

Second Quarter - The company's second quarter 2011 diluted, pre-split earnings per share guidance range is $1.42 to $1.48 on volume point growth of 10.0 percent to 12.0 percent and net sales growth of 19.0 percent to 21.0 percent compared to the same period in 2010, respectively, and an effective tax rate range of 28.3 percent to 29.3 percent. The company's second quarter 2011 capital expenditures are expected to be in the range of $18.0 million to $23.0 million.

Fiscal 2011 - The company's fiscal 2011 diluted, pre-split earnings per share guidance range is $5.54 to $5.78 on volume point growth of 12.0 percent to 14.0 percent and net sales growth of 18.0 percent to 20.0 percent compared to the same period in 2010, respectively, and an effective tax rate range of 28.0 percent to 29.0 percent. The company's fiscal 2011 capital expenditures are expected to be in the range of $80.0 million to $90.0 million.

Shareholders Approved Stock Split

As reported, the two-for-one stock split previously approved by the Herbalife board of directors was approved by the shareholders on April 28, 2011. The stock split will go into effect by the subdivision of each outstanding Common Share of a par value of $0.002 each into two Common Shares of a par value of $0.001 each and a proportional amendment of the authorized share capital. The record date for the stock split will be May 10, 2011. Each shareholder of record as of the close of business on the record date will receive one additional Common Share for every share held. The new shares will be distributed on or about May 17, 2011.

Announces Quarterly Dividend

The company reported today that its board of directors has approved a post-stock split dividend of $0.20 per share to shareholders of record effective May 24, 2011 payable on June 7, 2011.

First Quarter Earnings Conference Call

Herbalife's senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, May 3, 2011 at 8 a.m. PDT (11 a.m. EDT).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 57487434). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (800) 642-1687 for domestic callers or (706) 645-9291 for international callers (conference ID 57487434). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 75 countries through a network of approximately 2.3 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

FORWARD-LOOKING STATEMENTS

This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words "may," "will," "estimate," "intend," "continue," "believe," "expect" or "anticipate" and any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

    --  any collateral impact resulting from the ongoing worldwide financial
        "crisis," including the availability of liquidity to us, our customers
        and our suppliers or the willingness of our customers to purchase
        products in a recessionary economic environment;
    --  our relationship with, and our ability to influence the actions of, our
        distributors;
    --  improper action by our employees or distributors in violation of
        applicable law;
    --  adverse publicity associated with our products or network marketing
        organization;
    --  changing consumer preferences and demands;
    --  our reliance upon, or the loss or departure of any member of, our senior
        management team which could negatively impact our distributor relations
        and operating results;
    --  the competitive nature of our business;
    --  regulatory matters governing our products, including potential
        governmental or regulatory actions concerning the safety or efficacy of
        our products and network marketing program, including the direct selling
        market in which we operate;
    --  legal challenges to our network marketing program;
    --  risks associated with operating internationally and the effect of
        economic factors, including foreign exchange, inflation, disruptions or
        conflicts with our third party importers, pricing and currency
        devaluation risks, especially in countries such as Venezuela;
    --  uncertainties relating to the application of transfer pricing, duties,
        value added taxes, and other tax regulations, and changes thereto;
    --  uncertainties relating to interpretation and enforcement of recently
        enacted legislation in China governing direct selling;
    --  our inability to obtain the necessary licenses to expand our direct
        selling business in China;
    --  adverse changes in the Chinese economy, Chinese legal system or Chinese
        governmental policies;
    --  our dependence on increased penetration of existing markets;
    --  contractual limitations on our ability to expand our business;
    --  our reliance on our information technology infrastructure and outside
        manufacturers;
    --  the sufficiency of trademarks and other intellectual property rights;
    --  product concentration;
    --  changes in tax laws, treaties or regulations, or their interpretation;
    --  taxation relating to our distributors;
    --  product liability claims; and
    --  whether we will purchase any of our shares in the open markets or
        otherwise.

We do not undertake any obligation to update or release any revisions to any forward-looking statements or report any events or circumstances after the date hereof or to reflect the occurrences of unanticipated events, except as required by law.

RESULTS OF OPERATIONS:


Herbalife Ltd.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

                                Quarter Ended

                                3/31/2011    3/31/2010

North America                   $ 167,000    $ 151,259

Mexico                            103,877      71,849

South and Central America         125,277      91,330

EMEA                              153,937      130,824

Asia Pacific                      199,303      141,013

China                             45,702       32,358

Worldwide net sales               795,096      618,633

Cost of Sales                     162,793      140,472 1

Gross Profit                      632,303      478,161

Royalty Overrides                 264,377      207,319

SGA                               244,526      206,883 1

Operating Income                  123,400      63,959

Interest Expense - net            2,648        1,953

Income before income taxes        120,752      62,006

Income Taxes                      33,184       10,135  1

Net Income                        87,568       51,871

Basic Shares                      59,103       60,160

Diluted Shares                    61,908       62,672

Basic EPS                       $ 1.48       $ 0.86

Diluted EPS                     $ 1.41       $ 0.83

Dividends declared per share    $ 0.25       $ 0.20




   Includes impact of items related to adoption of highly-inflationary
1  accounting in Venezuela that are further discussed in Schedule B -
   "Reconciliation of Non-GAAP Financial Measures"




Herbalife Ltd.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

                                               Mar 31,          Dec 31,

                                               2011             2010

ASSETS

Current Assets:

Cash & cash equivalents                        $ 260,766        $ 190,550

Receivables, net                                 107,893          85,612

Inventories                                      184,321          182,467

Prepaid expenses and other current assets        110,400          93,963

Deferred income taxes                            42,355           42,994

Total Current Assets                             705,735          595,586

Property and equipment, net                      187,733          177,427

Deferred compensation plan assets                18,732           18,536

Deferred financing cost, net                     5,451            998

Other assets                                     26,639           25,880

Marketing related intangibles and other and      310,815          310,894
other intangible assets, net

Goodwill                                         102,899          102,899

Total Assets                                   $ 1,358,004      $ 1,232,220

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Accounts payable                               $ 53,725         $ 43,784

Royalty Overrides                                173,076          162,141

Accrued compensation                             52,540           69,376

Accrued expenses                                 138,523          141,867

Current portion of long term debt                1,753            3,120

Advance sales deposits                           56,928           35,145

Income taxes payable                             18,340           15,383

Total Current Liabilities                        494,885          470,816

Non-current liabilities

Long-term debt, net of current portion           181,188          175,046

Deferred compensation                            23,197           20,167

Deferred income taxes                            55,220           55,572

Other non-current liabilities                    23,216           23,407

Total Liabilities                                777,706          745,008

Contingencies

Shareholders' equity:

Common shares                                    119              118

Additional paid in capital                       262,617          257,375

Accumulated other comprehensive loss             (12,074   )      (27,285   )

Retained earnings                                329,636          257,004

Total Shareholders' Equity                       580,298          487,212

Total Liabilities and Shareholders' Equity     $ 1,358,004      $ 1,232,220




Herbalife Ltd.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

                                                    Quarter Ended

                                                    3/31/2011       3/31/2010

CASH FLOWS FROM OPERATING ACTIVITIES

Net income                                          $ 87,568        $ 51,871

Adjustments to reconcile net income to net cash
provided by operating activities:

Depreciation and amortization                         18,562          17,262

(Excess) Deficiency in tax benefits from              (6,794   )      (2,606   )
share-based payment arrangements

Share-based compensation expenses                     5,604           5,295

Amortization of discount and deferred financing       149             124
costs

Deferred income taxes                                 921             (13,671  )

Unrealized foreign exchange transaction (gain)        1,383           (2,608   )
loss

Write-off of deferred financing costs                 914             --

Foreign exchange loss from adoption of highly         --              15,131
inflationary accounting in Venezuela

Other                                                 751             1,078

Changes in operating assets and liabilities:

Receivables                                           (20,493  )      (12,048  )

Inventories                                           4,184           474

Prepaid expenses and other current assets             (13,582  )      (4,357   )

Other assets                                          (251     )      (71      )

Accounts payable                                      8,861           19,311

Royalty overrides                                     7,340           (7,081   )

Accrued expenses and accrued compensation             (21,122  )      (14,022  )

Advance sales deposits                                20,998          26,741

Income taxes payable                                  9,494           5,566

Deferred compensation plan liability                  3,030           1,044

NET CASH PROVIDED BY OPERATING ACTIVITIES             107,517         87,433

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property                                 (28,325  )      (11,623  )

Proceeds from sale of property                        2               3

Deferred compensation plan assets                     (197     )      (79      )

NET CASH USED IN INVESTING ACTIVITIES                 (28,520  )      (11,699  )

CASH FLOWS FROM FINANCING ACTIVITIES

Dividends paid                                        (14,819  )      (12,065  )

Borrowings from long-term debt                        289,700         102,000

Principal payments on long-term debt                  (284,924 )      (104,951 )

Deferred financing costs                              (5,516   )      --

Share repurchases                                     (8,965   )      (28,010  )

Excess (Deficiency in) tax benefits from              6,794           2,606
share-based payment arrangements

Proceeds from exercise of stock options and sale      1,689           1,888
of stock under employee stock purchase plan

NET CASH USED IN FINANCING ACTIVITIES                 (16,041  )      (38,532  )

EFFECT OF EXCHANGE RATE CHANGES ON CASH               7,260           (22,732  )

NET CHANGE IN CASH AND CASH EQUIVALENTS               70,216          14,470

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD        190,550         150,801

CASH AND CASH EQUIVALENTS, END OF PERIOD              260,766         165,271

CASH PAID DURING THE PERIOD

Interest paid                                       $ 2,093         $ 2,691

Income taxes paid, net                              $ 21,874        $ 13,430



SUPPLEMENTAL INFORMATION

Schedule A: Financial Guidance

2011 Guidance

For the Three Months Ending June 30, 2011 and Twelve Months Ending December 31, 2011


                            Three Months Ending           Twelve Months Ending

                            June 30, 2011                 December 31, 2011

                            Low        High               Low        High

Volume point growth vs        10.0 %     12.0 %             12.0 %     14.0 %
2010

Net sales growth vs 2010      19.0 %     21.0 %             18.0 %     20.0 %

EPS - Pre Stock Split       $ 1.42     $ 1.48             $ 5.54     $ 5.78

EPS - Post Stock Split      $ 0.71     $ 0.74             $ 2.77     $ 2.89

Cap Ex ($ millions)         $ 18.0     $ 23.0             $ 80.0     $ 90.0

Effective Tax Rate            28.3 %     29.3 %             28.0 %     29.0 %



SCHEDULE B: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(unaudited), (Dollars in Thousand, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as "non-GAAP financial measures." Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investor in analyzing period to period comparisons of the Company's results.

The following is a reconciliation of net income and diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:


Herbalife Ltd.

Supplemental Schedule

Non-GAAP Financial Measures

(In thousands, except per share data)

(Unaudited)

                              Quarter Ended 3/31/2011

                              Reported                   Adjusted

                              (GAAP)      Adjustment     (Non-GAAP)

Net Sales                       795,096                    795,096

Cost of Sales                   162,793                    162,793

Gross Profit                    632,303     -              632,303

Royalty Overrides               264,377                    264,377

SGA                             244,526                    244,526

Operating Income                123,400     -              123,400

Interest Expense - net          2,648       (914 )   1     1,734

Income before income taxes      120,752     914            121,666

Income Taxes                    33,184      214      1     33,398

Net Income                      87,568      700            88,268

Diluted EPS                   $ 1.41      $ 0.01         $ 1.43     2




1  Write-off of unamortized deferred financing costs resulting from the debt
   refinancing arrangement in March 2011.

2  Amounts may not total due to rounding.




Herbalife Ltd.

Supplemental Schedule

Non-GAAP Financial Measures

(In thousands, except per share data)

(Unaudited)

                              Quarter Ended 3/31/2010

                              Reported    Venezuela       Adjusted

                              (GAAP)      Items           (Non-GAAP)

Net Sales                       618,633                     618,633

Cost of Sales                   140,472     (12,715 ) 1     127,757

Gross Profit                    478,161     12,715          490,876

Royalty Overrides               207,319                     207,319

SGA                             206,883     (11,390 ) 2     195,493

Operating Income                63,959      24,105          88,064

Interest Expense - net          1,953                       1,953

Income before income taxes      62,006      24,105          86,111

Income Taxes                    10,135      14,452    3     24,587

Net Income                      51,871      9,653           61,524

Diluted EPS                   $ 0.83      $ 0.15          $ 0.98




   Incremental U.S. dollar costs of 2009 imports which were recorded at the
1  unfavorable parallel market exchange rate and were not devalued based on
   2010 exchange rates but rather recorded at their historical dollar costs as
   products were sold

   Includes $15,131 foreign exchange loss related to remeasurement of
   Venezuela's monetary assets and liabilities resulting from adoption of
2  highly inflationary accounting and $3,741 foreign exchange gain resulting
   from receipt of U.S. dollar approved by CADIVI at the official exchange rate
   relating to 2009 product importations which were previously registered with
   CADIVI

3  Favorable income taxes related to Venezuela becoming highly inflationary
   economy



The following is a reconciliation of total long-term debt to net debt:


                                               3/31/2011     12/31/2010

Total long-term debt (current and long-term    $ 182,941     $ 178,166
portion)

Less: Cash and cash equivalents                  260,766       190,550

Net debt                                       $ (77,825 )   $ (12,384 )




    Source: Herbalife Ltd.